Purchases and Sales Made in Q1 2022 in Novo Cure LTD (NVCR)
This table provides information about the institutional ownership of Novo Cure LTD (NVCR) during Q1 2022. The information is specifically focused on institutions that hold shares of NovoCure Ltd.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
May 12, 2023
Q1 2022
|
Norges Bank
Oslo, Q8 |
SELL
|
- |
-80.7K- 8.29% |
$4.85M - $6.82M
|
893K
$24.5M
|
|
May 13, 2022
Q1 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-96.8K- 11.71% |
$5.82M - $8.18M
|
730K
$20M
|
|
May 16, 2022
Q1 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-105K- 34.14% |
$6.34M - $8.92M
|
203K
$5.58M
|
|
May 16, 2022
Q1 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-127K- 97.8% |
$7.63M - $10.7M
|
2.86K
$78.4K
|
|
May 13, 2022
Q1 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-131K- 73.21% |
$7.89M - $11.1M
|
48K
$1.32M
|
|
May 04, 2022
Q1 2022
|
Banque Pictet & Cie Sa
|
SELL
|
- |
-248K- 82.69% |
$14.9M - $21M
|
51.9K
$1.43M
|
|
May 16, 2022
Q1 2022
|
Darsana Capital Partners LP
New York, NY |
SELL
|
- |
-259KClosed |
$15.6M - $21.9M
|
0
$0
|
|
May 05, 2022
Q1 2022
|
Baillie Gifford & CO
|
SELL
|
- |
-274K- 2.85% |
$16.5M - $23.2M
|
9.34M
$256M
|
|
May 16, 2022
Q1 2022
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-287K- 73.2% |
$17.3M - $24.3M
|
105K
$2.88M
|
|
Oct 27, 2022
Q1 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-299K- 29.05% |
$18M - $25.2M
|
730K
$20M
|
|
May 16, 2022
Q1 2022
|
Macquarie Group LTD
Australia, C3 |
SELL
|
- |
-314K- 77.91% |
$18.9M - $26.6M
|
89.1K
$2.45M
|
|
May 09, 2022
Q1 2022
|
Norges Bank
Oslo, Q8 |
SELL
|
- |
-868KClosed |
$52.2M - $73.4M
|
0
$0
|